| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |